Erudio Healtherudio.com
Drug
Asciminib trials: what clinicians said in public
No HCP commentary report on a trial studying asciminib yet. Erudio has found public clinician commentary on 2 clinical trials studying asciminib: ASC2ESCALATE and ASC4FIRST. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| ASC4FIRST NCT04971226 · Novartis Pharmaceuticals DeepView → | newly diagnosed Ph+ chronic-phase chronic myeloid leukemia | Phase 3 | Deep | View | |||
| ASC2ESCALATE NCT05384587 · Novartis Pharmaceuticals StandardView → | first-line or second-line chronic-phase chronic myeloid leukemia | Phase 2 | Standard | View | |||